[Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?].
Thomas
Thierry
T
Hôpital Bellevue, Saint-Etienne.
Reach
Gérard
G
Lespessailles
Eric
E
D000368:Aged; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D012968:Etidronic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D005081:Exercise Therapy; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D005602:France; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D010349:Patient Compliance; D010353:Patient Education as Topic; D000068296:Risedronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000068296:Risedronic Acid; D012968:Etidronic Acid